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Abstract
Two radioaerosol preparations, TechneScan®-DTPA (99mTc-DTPA, 40
mCi/3 ml; IPEN-CNEN, São Paulo, SP, Brazil) and TechneScan®-
DTPA/AEROSOL (99mTc-DTPA/A, 15 mCi/1.5 ml with 0.5 ml ethanol;
Mallinckrodt Medical, St. Louis, MO, USA), were compared in pulmo-
nary ventilation studies in terms of total radiocounts and clearance after
inhalation. An aerosol with ethanol is supposed to better distribute the
radioparticles in the lungs. Twenty normal nonsmoking volunteers (10
men and 10 women), mean age of 23.2 years (range: 20 to 35 years), were
studied. Images were obtained immediately and 30, 60 and 90 min after
inhalation. Total and regional counts were obtained and the clearance
half-lives of both lungs were determined. There was no difference in total
counts between the two types of radioaerosol at any time (mean of
~188,000 cpm for male and female subjects at time zero in both
aerosols). The highest count was obtained in the middle region of both
lungs (P<0.001) with both preparations. The clearance half-life did not
differ between aerosols (mean of ~80-88 min for male and female
subjects for both aerosols). Small nonsignificant regional differences
were observed. No differences between genders or between right and left
lung were observed. 99mTc-DTPA/A generated the highest output of
radioaerosol. 99mTc-DTPA with alcohol costs approximately five times
more than the aerosol without alcohol. The present results show that
either kind of aerosol may be adopted routinely for use in pulmonary
examinations without affecting diagnosis. We suggest that the amount of
740 mBq (20 mCi) of 99mTc-DTPA in 1.5 ml saline can be used for
routine examinations resulting in reduction of costs in pulmonary venti-
lation studies without diagnostic impairment.
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Introduction
Improvements in nebulizer efficiency has
led to the widespread use of radioaerosols
for the evaluation of global and regional
pulmonary ventilation (1). The measurement
of pulmonary radioaerosol clearance may
indicate the presence of various interstitial
diseases and is based on the ability of the
alveoli to absorb liquid particles and rapidly
remove them (2). The radioaerosol most com-
monly utilized for this purpose is diethyl-
enetriaminepentaacetic acid (DTPA) labeled
with technetium-99m (99mTc). 99mTc-DTPA
is a hydrophilic molecule with very low lipid
solubility. After deposition in the alveoli it
diffuses across the interepithelial pores of
the epithelium with no apparent active trans-
1334
Braz J Med Biol Res 36(10) 2003
C.M. Silveira et al.
port mechanism. 99mTc-DTPA clearance can
be used as a measurement of the integrity of
the alveolar-capillary barrier (3,4).
Various devices have been used for aero-
sol generation in the study of pulmonary
ventilation (5-11). The most commonly used
one is the jet nebulizer. This device gener-
ates droplets of a median mass diameter of
1.2 to 6.9 µm and a geometric standard
deviation of 1.7 to 2.2 µm, depending mainly
on the air flow rate (12). The Ultravent™
system (Mallinckrodt Medical Inc., St. Louis,
MO, USA) (13) produces excellent results in
intrapulmonary radioaerosol distribution af-
ter short periods of inhalation (4,14,15). It
generates particles with a median mass di-
ameter of 0.9 µm according to manufacturer
specifications (16).
The median mass aerodynamic diameter
of radioaerosols generated by commercial
nebulizers has been studied in order to char-
acterize particle size distribution. This pa-
rameter is relevant since the lung deposition
is determined by generated particle size and
by particle aerodynamic behavior (17).
The DTPA solution which contains etha-
nol in its reconstitution formula is consid-
ered to increase the efficiency of aerosol
distribution by decreasing the surface ten-
sion and by increasing the volatility and
formation of aerosol droplets, without a
change in particle size (14).
The objective of the present study was to
compare the lung distribution of two radio-
aerosols with different reconstitution formu-
las in pulmonary ventilation studies con-
ducted on healthy individuals of both gen-
ders.
Patients and Methods
Twenty healthy nonsmoking volunteers
(10 men and 10 women) aged 20 to 35 years
(mean: 23.2 years) were included in the pres-
ent investigation. The study was carried out
in the Nuclear Medicine Department, Fed-
eral University of São Paulo, Brazil. Sub-
jects had normal clinical examinations, spiro-
metric studies and thoracic radiographs. The
study was approved by the Ethics Commit-
tee of Hospital São Paulo, Federal Univer-
sity of São Paulo (UNIFESP) and subjects
gave informed written consent to partici-
pate.
Each volunteer underwent two pulmonary
ventilation studies conducted 30 days apart
using two different nebulizers, TechneScan®
DTPA (99mTc-DTPA; IPEN-CNEN, São
Paulo, SP, Brazil) and TechneScan® DTPA/
AEROSOL (99mTc-DTPA/A, Mallinckrodt).
99mTc-DTPA was used in the first study
with an activity of 1480 MBq in 3 ml physi-
ological saline solution. 99mTc-DTPA/A was
used in the second study with an activity of
555 MBq in 1 ml, with 0.5 ml ethanol (98%,
v/v) added after reconstitution. Both studies
used the same jet nebulizer (Ultravent™,
Mallinckrodt) which generates particles with
a median mass diameter of 0.9 µm (16). The
same air flow rate was used in both studies.
To estimate the volume of radioactive
solution effectively consumed during the
study, immediately after inhalation the quan-
tity of residual solution remaining in the cup
and in the tubes was determined by weighing
the solution of the nebulizer system. Five
samples with 3 ml saline solution (solution
1) and five samples with 1 ml saline solution
supplemented with 0.5 ml ethanol (solution
2) were nebulized over a period of 5 min.
A gamma camera (Elscint SPX-4HR) was
used for image acquisition in a 256 x 256 x
16 matrix. The volunteers were placed in the
sitting position and inhaled the radioactive
solution for 5 min with nasal obstruction.
When inhalation was completed they were
placed in the supine position and the images
were acquired immediately and 30, 60 and
90 min later in posterior, right and left poste-
rior oblique projections. We used the ob-
lique projection images to detect any exist-
ing alterations that were not detected previ-
ously. The acquisition time obtained with
the first image (400 kcounts) was utilized for
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subsequent images. All images were stored
in a computer for later processing. Back-
ground radioactivity was not subtracted due
to technical problems concerning its local-
ization.
The total and regional counts were ob-
tained in the posterior projection. Total counts
were obtained from a rectangular region of
interest drawn automatically over both lungs.
Each lung was then divided into three equal
areas named upper, middle and lower (Fig-
ure 1). All count values were corrected for
physical 99mTc decay. Clearance half-lives
measured in minutes in each image were
determined by linear regression, plotting the
logarithmic function of the total and regional
counts against time, as shown in the example
in Figure 5.
The Friedman test for analysis of vari-
ance was applied to compare the counts
obtained with the two types of radioaerosols
in each gender at times 0, 30, 60 and 90 min,
and in the different regions of the lungs
(upper, middle, lower). The Wilcoxon test,
which demonstrates the difference between
two dependent samples, was applied to com-
pare the total and regional counts obtained
with the two radioaerosols (18). The Student
t-test was used to compare the mean clear-
ance half-lives of the radioaerosols in both
lungs, in the different regions and between
genders. A level of 5% was fixed for the
rejection of the null hypothesis. Significant
values are marked with an asterisk.
Results
The anthropometric data of the subjects
and the results obtained in the evaluation
of pulmonary function are described in
Table 1.
A progressive decrease occurred in total
counts of 99mTc-DTPA and 99mTc-DTPA/A
at 30, 60 and 90 min in both the right and left
lungs and in both genders (Table 2 and Fig-
ure 2). Total counts obtained after 99mTc-
DTPA inhalation for the right and left lungs
and for both genders were not significantly
different from the radioactive counts ob-
tained after 99mTc-DTPA/A inhalation (Fig-
ure 3).
The highest regional radioactive counts
obtained after both 99mTc-DTPA and 99mTc-
DTPA/A radioaerosol inhalation occurred
in the middle region of the lung (P≤0.0001),
followed by the lower and upper regions,
respectively. There was no significant dif-
ference between males and females for DTPA
and DTPA/A or between the two aerosols.
Figure 4 shows only male curves because
female ones are exactly the same.
Regional and total values for the clear-
ance half-lives of the radioaerosols ranged
from 74 to 91 min for both genders and for
the upper, middle and lower regions of the
Table 1. Anthropometric and ventilation function
data of 20 normal individuals.
Mean ± SD Median
Age (years) 23.2 ± 3.9 21.5
Height (cm) 170.9 ± 8.9 171.0
Weight (kg) 69.5 ± 11.8 68.3
FVC
Liter 4.8 ± 1.1 4.6
% predicted 107.9 ± 13.6 104.4
FEV1
Liter 3.9 ± 0.8 3.8
% predicted 104.2 ± 11.6 102.0
FEV1/FVC
% 83.6 ± 6.4 84.0
% predicted 96.3 ± 6.6 97.7
FEV1 = forced expiratory volume in one second.
FVC = forced vital capacity.
Figure 1. Lung segmentation in
posterior projection defining
three segments: upper, middle
and lower.
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right and left lungs, as shown in Table 3. The
clearance half-lives in the upper left lungs
differed between males and females. There
was no significant difference in clearance
half-lives between lungs in the two genders
(P>0.05). Figure 5 shows only female curves
because both are exactly the same.
The mean quantity of solutions consumed
during the nebulization process was 0.78 ±
0.05 ml for solution 1 and 1.16 ± 0.11 ml
for solution 2, resulting in flow rates of 0.16
and 0.23 ml/min, respectively, as shown in
Table 4.
Discussion
Regional DTPA acquisition values were
homogeneously distributed, which is the
same as obtained in other studies conducted
on normal subjects, in the sitting position
(19) or in ventral decubitus (20).
The middle region of the right and left
lungs showed the greatest radioaerosol depo-
sition when compared with the lower and
upper regions in both genders (P<0.05), an
occurrence also observed by Köhn et al.
(21). Greater radioactive deposition may be
expected to occur in the lower lobes, assum-
ing that this is the pulmonary region which
Figure 3. 99mTc-DTPA and
99mTc-DTPA/A counts obtained
immediately after inhalation
(time 0) for the right (R) and the
left (L) lungs of 20 healthy indi-
viduals. There were no signifi-
cant difference between 99mTc-
DTPA and 99mTc-DTPA/A radio-
aerosols. 99mTc-DTPA, 99mTc-
DTPA/A = technetium-99m-di-
ethylenetriaminepentaacetic
acid without and with alcohol,
respectively.
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Table 2. Total counts obtained immediately after inhalation (time 0) and after 30, 60 and 90 min, in the right and left lungs of healthy individuals.
Time DTPA DTPA/A
Female Male Female Male
Right lung
0 min 188,430 ± 5,937 (3.2) 186,800 ± 14,013 (7.5) 188,004 ± 6,667 (3.5) 187,591 ± 10,080 (5.3)
30 min 134,576 ± 17,508 (13) 136,565 ± 17,190 (12.6) 118,365 ± 22,472 (19.0) 124,049 ± 14,130 (11.4)
60 min 97,087 ± 14,031 (14.4) 102,477 ± 17,941 (17.5) 87,569 ± 19,376 (22.1) 97,756 ± 14,617 (14.9)
90 min 73,661 ± 16,143  (21.9) 80,029 ± 17,679 (22.1) 73,031 ± 20,527 (28.1) 78,669 ± 15,843 (20.1)
Left lung
0 min 181,693 ± 8,292 (4.5) 181,239 ± 9,344 (5.1) 177,816 ± 6,656 (3.7) 178,433 ± 9,343 (5.2)
30 min 135,021 ± 9,970* (14.8) 130,778 ± 9,600* (7.3) 112,765 ± 18,636 (16.5) 117,814 ± 13,415 (11.4)
60 min 97,660 ± 16,422* (16.8) 98,679 ± 16,786 (17.0) 85,208 ± 15,580 (18.3) 93,451 ± 13,914 (14.9)
90 min 75,746 ± 19,731 (26.0) 75,670 ± 14,855 (19.6) 71,869 ± 19,796 (27.5) 74,943 ± 14,898 (19.9)
DTPA, DTPA/A = diethylenetriaminepentaacetic acid without and with alcohol, respectively. Data are reported as means ± SD with the
coefficient of variation in parentheses for 10 females and 10 males for 99mTc-DTPA and 9 females and 10 males for 99mTc-DTPA/A radioaerosols.
*P<0.05 compared to DTPA/A (Friedman test).
A B
Figure 2. Inhalation study in a 22-year-old normal woman in the posterior projection during the
time of the study. Visual inspection shows no difference between DTPA (A) and DTPA/A (B)
radioaerosols. Both have the same gray scale. Notice the renal aspect of DTPA elimination.
DTPA, DTPA/A = diethylenetriaminepentaacetic acid without and with alcohol, respectively.
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contains the greatest number of alveoli (22-
25).
Comparison of our results with previ-
ously published data is difficult. Studies of
pulmonary ventilation with radioaerosols
generally do not describe the regional con-
centration and usually discuss the pulmo-
nary clearance rate in pulmonary diseases
(26-29). Various studies have utilized 99mTc-
DTPA radioaerosol with activities between
740 and 1850 MBq in a volume of 2 to 4 ml
saline solution for pulmonary ventilation
studies, concentrations similar to those em-
ployed in our study (30-34). Some authors
have reported the use of higher activities in
their investigations (35).
Consumption of a smaller quantity of
99mTc-DTPA/A than 99mTc-DTPA was dem-
onstrated during the same inhalation time,
suggesting that this preparation achieves more
efficient aerosol generation or particle flow.
Sirr et al. (14) did not observe any significant
alteration in the median mass diameter of the
particles obtained from the nebulization of a
solution of 99mTc-DTPA/A radioaerosol con-
taining 20% ethanol in comparison to a solu-
tion not containing it. However, a significant
increase in the aerosol particles per unit time
was observed. These investigators postulated
that the introduction of ethanol into the 99mTc-
DTPA/A solution produces a significant de-
crease in the surface tension of the liquid,
mainly increasing the volatility and the effi-
ciency of the aerosol particles.
There was no significant difference in
clearance half-life between the two radio-
aerosols. Sirr et al. (14) also observed no
alteration in the clearance time using various
concentrations of ethanol (0-40%). The
DTPA radioaerosol clearance half-lives ob-
tained in our group of healthy individuals are
comparable to those described in the litera-
ture, despite the fact that in some investiga-
tions the subjects were studied in supine
(36), ventral decubitus (20) or sitting (19,37)
positions.
No difference in clearance half-lives was
observed between the right and left lung, a
result also reported by others (15,20,37).
Radioaerosol studies require aerosol par-
ticles to be of small size and to have a very
low probability of prolonged pulmonary re-
tention. If large quantities of particles impact
in the large airways, the penetration and
distribution of the particles in the distal air-
Table 3. DTPA and DTPA/A radioaerosol clearance half-lives in the upper, middle and
lower regions of the right and left lungs in both genders.
Right lung Left lung
Female Male Mean ± SD Female Male Mean ± SD
Upper
DTPA 79.43 90.63 84.03 ± 7.92 88.61 87.84 88.23 ± 0.54*
DTPA/A 81.82 87.09 84.46 ± 3.73 84.66 87.09 85.88 ± 1.72*
Middle
DTPA 84.31 89.66 86.99 ± 3.78 89.33 87 88.17 ± 1.65
DTPA/A 80.48 89.37 84.93 ± 6.29 83.16 89.71 86.44 ± 4.63
Lower
DTPA 83.13 75.9 79.52 ± 5.11 85.58 74.09 79.84 ± 8.12
DTPA/A 75.27 83.41 79.34 ± 5.76 79.15 85.8 82.48 ± 4.70
Total
DTPA 81.35 89.19 85.27 ± 5.54 86.28 87.02 86.65 ± 0.52
DTPA/A 79.04 86.95 83.00 ± 5.59 83.98 87.27 85.63 ± 2.33
DTPA, DTPA/A = diethylenetriaminepentaacetic acid without and with alcohol, re-
spectively. Data are reported in min.
*P<0.05 significant statistical difference between genders (Student t-test).
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Figure 4. Regional counts ob-
tained immediately after inhala-
tion (time 0) and 30, 60 and 90
min later in the upper (U), middle
(M) and lower (L) regions of the
right and left  lungs of 10 healthy
individual males for 99mTc-DTPA
(top) and for 99mTc-DTPA/A (bot-
tom). 99mTc-DTPA, 99mTc-
DTPA/A = technetium-99m-di-
ethylenetriaminepentaacetic
acid without and with alcohol,
respectively.
Right lung Left lung
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Figure 5. Total counts of the
DTPA and DTPA/A radioaerosols
for analysis of pulmonary clear-
ance (min) in the right (top) and
left (bottom) lungs of female
subjects, corrected for 30-, 60-
and 90-min decay. DTPA, DTPA/
A = diethylenetriaminepenta-
acetic acid without and with al-
cohol, respectively.
nents of the nebulizer system was detected,
suggesting that particles below 1 µm in di-
ameter were being produced.
The fraction of aerosol particles that en-
ter the airways depends on their size, physi-
cal and chemical characteristics of the aero-
sol, as well as on the morphological and
physiological characteristics of the airways,
tidal volume and respiratory frequency (38).
Various studies have analyzed the depo-
sition of radioaerosols as a function of tidal
volume and respiratory frequency (29,39).
Lippmann and Albert (40) have suggested
that an adequate pulmonary ventilation im-
age depends on airflow and volume. During
our study, we tried to establish identical
conditions in the two tests, encouraging the
subjects to breathe calmly with a constant
airflow, tidal volume and respiratory fre-
quency. This procedure may produce a lami-
nar airflow inside the respiratory airways,
preventing turbulence and minimizing the
impact of the particles on the upper airways,
with a consequent good distribution of the
radioactive solution in the pulmonary fields.
The higher level of radioactivity utilized
in the preparation of the 99mTc-DTPA radio-
aerosol and the greater volume of liquid
rejected, 3 ml on average, in each experi-
ment required the maintenance of controlled
technical-operational conditions to avoid
possible contamination of the environment
and of the technicians involved in equip-
ment handling. This rejection suggests that
the volume of solution utilized for nebuliza-
tion was greater than necessary.
An interesting point to be raised con-
cerns costs. The method that uses DTPA
associated with alcohol costs approximately
five times more than the DTPA aerosol with-
out alcohol. However, based on the flow
generated by DPTA without alcohol (0.16
ml/min), a radioactive concentration of 740
MBq in 1.5 ml (20 mCi/1.5 ml) would be
sufficient to generate a radioactivity level
(2.1 mCi/min) equivalent to that obtained
when 1480 MBq in 3 ml (40 mCi/3 ml) is
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ways will be inadequate, affecting the image
obtained (2). In our study, the radioaerosol
was distributed homogenously in the various
lung fields and radioactivity concentrations
were not detected in the upper airways. Also,
no impact of the radioaerosol on the compo-
Table 4. Residual saline solution (RSS) and consumed volume (∆) generated by the
nebulization of saline solution (solution 1) and saline solution with 0.5 ml ethanol added
(solution 2).
Solution 1 RSS ∆ Solution 2 RSS ∆
1 3 2.2 0.8 1.5 0.3 1.2
2 3 2.3 0.7 1.5 0.5 1.0
3 3 2.2 0.8 1.5 0.4 1.1
4 3 2.2 0.8 1.5 0.2 1.3
5 3 2.2 0.8 1.5 0.3 1.2
Mean ± SD 3 2.22 ± 0.05 0.78 ± 0.05 1.5 0.34 ± 0.11 1.16 ± 0.11
Data are reported in ml.
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utilized in the routine examinations. This
value is approximately equal to 2.3 mCi/ml
generated when DTPA with alcohol (0.23
ml/min) is utilized. The radioactive concen-
tration may be estimated as follows: (15
mCi/1.5 ml) x 0.23 ml/min = 2.3 mCi/min.
Our suggestion is that 99mTc-DTPA without
alcohol could be prepared as 20 mCi in 1.5
ml saline solution with the same efficiency
as the solution prepared before with 40 mCi
in 3 ml saline. A vial with 99mTc-DTPA costs
R$19.00 (US$5.28) and can be used for four
patients (cost of one patient: US$1.32); a
vial of the 99mTc-DTPA/A costs R$23.00
(US$6.34) and is enough for just one patient.
This would greatly reduce the cost of the
examination and avoid manipulation of liq-
uid waste which can cause eventual con-
tamination.
We may conclude that there was no sta-
tistically significant difference between the
total and regional radioactivity counts and
the clearance half-lives after the utilization
of the 99mTc-DTPA and 99mTc-DTPA/A
radioaerosols in the two lungs, in healthy
individuals of both genders. 99mTc-DTPA/A
showed a greater generation of aerosol which
may be explained by the presence of ethanol,
although no change in the radioaerosol clear-
ance half-life occurred.
Although the use of 555 MBq of 99mTc-
DTPA/A in pulmonary ventilation studies
seems convenient based on its yield effi-
ciency, we suggest that 740 MBq of 99mTc-
DTPA in 1.5 ml saline be used in routine
examinations because this would permit a
reduction in operational costs, assuming that
this volume would give the same diagnostic
quality.
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